FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

[ad_1]

FDA announces plan for folinic acid to be accessible prescription treatment for children with autism
Food and Drug Administration Commissioner Dr. Martin A. Makary announced that the FDA is filing a federal register notice to change the label on Leucovorin, so it can be prescribed to treat children with autism.

[ad_2]

Source link

Posted in

Swedan Margen

I focus on highlighting the latest in business and entrepreneurship. I enjoy bringing fresh perspectives to the table and sharing stories that inspire growth and innovation.

Leave a Comment